Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab.

Hahn TJ, McKeone DJ, Beal JW, Ericson JE, Halstead ES

Open source

DOI
10.3389/fped.2023.1340360
Published
2023
Container
Frontiers in pediatrics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fped.2023.1340360,
  title = {Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab.},
  author = {Hahn TJ and McKeone DJ and Beal JW and Ericson JE and Halstead ES},
  year = {2023},
  journal = {Frontiers in pediatrics},
  doi = {10.3389/fped.2023.1340360},
  url = {https://doi.org/10.3389/fped.2023.1340360}
}

RIS

TY  - JOUR
TI  - Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab.
AU  - Hahn TJ
AU  - McKeone DJ
AU  - Beal JW
AU  - Ericson JE
AU  - Halstead ES
PY  - 2023
JO  - Frontiers in pediatrics
DO  - 10.3389/fped.2023.1340360
UR  - https://doi.org/10.3389/fped.2023.1340360
ER  - 

APA

TJ, H., DJ, M., JW, B., JE, E., & ES, H. (2023). Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab.. Frontiers in pediatrics. https://doi.org/10.3389/fped.2023.1340360

Source records